Johnson & Johnson (JNJ)
USD 159.07
(3.35%)
USD 159.07
(3.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 58.6 Billion USD | 6.08% |
| 2022 | 33.18 Billion USD | -3.53% |
| 2021 | 34.39 Billion USD | -0.08% |
| 2020 | 34.42 Billion USD | 2.66% |
| 2019 | 33.53 Billion USD | 0.65% |
| 2018 | 33.31 Billion USD | 4.19% |
| 2017 | 31.97 Billion USD | 10.1% |
| 2016 | 29.04 Billion USD | -4.0% |
| 2015 | 30.24 Billion USD | -0.65% |
| 2014 | 30.44 Billion USD | 1.45% |
| 2013 | 30.01 Billion USD | 5.18% |
| 2012 | 28.53 Billion USD | 0.06% |
| 2011 | 28.51 Billion USD | 8.56% |
| 2010 | 26.26 Billion USD | -2.6% |
| 2009 | 26.96 Billion USD | -7.8% |
| 2008 | 29.24 Billion USD | 3.97% |
| 2007 | 28.13 Billion USD | 14.55% |
| 2006 | 24.55 Billion USD | 5.9% |
| 2005 | 23.18 Billion USD | 10.09% |
| 2004 | 21.06 Billion USD | 11.95% |
| 2003 | 18.81 Billion USD | 16.34% |
| 2002 | 16.17 Billion USD | 3.79% |
| 2001 | 15.58 Billion USD | 1.74% |
| 2000 | 15.31 Billion USD | 5.29% |
| 1999 | 14.54 Billion USD | 17.11% |
| 1998 | 12.42 Billion USD | 4.19% |
| 1997 | 11.92 Billion USD | 5.43% |
| 1996 | 11.3 Billion USD | 13.61% |
| 1995 | 9.95 Billion USD | 19.17% |
| 1994 | 8.35 Billion USD | 10.33% |
| 1993 | 7.57 Billion USD | 2.88% |
| 1992 | 7.35 Billion USD | 11.96% |
| 1991 | 6.57 Billion USD | 13.76% |
| 1990 | 5.77 Billion USD | 14.85% |
| 1989 | 5.03 Billion USD | 7.14% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 10.42 Billion USD | 16.88% |
| 2024 Q1 | 8.59 Billion USD | -13.92% |
| 2024 Q2 | 8.92 Billion USD | 3.74% |
| 2023 Q4 | 9.99 Billion USD | 16.88% |
| 2023 Q2 | 8.69 Billion USD | 9.27% |
| 2023 Q3 | 8.54 Billion USD | -1.75% |
| 2023 Q1 | 7.96 Billion USD | -28.51% |
| 2023 FY | 35.19 Billion USD | 6.08% |
| 2022 Q2 | 9.92 Billion USD | 2.26% |
| 2022 Q3 | 8.46 Billion USD | -14.8% |
| 2022 Q4 | 11.13 Billion USD | 31.63% |
| 2022 FY | 33.18 Billion USD | -3.53% |
| 2022 Q1 | 9.71 Billion USD | -18.22% |
| 2021 Q1 | 8.61 Billion USD | -17.91% |
| 2021 FY | 34.39 Billion USD | -0.08% |
| 2021 Q4 | 11.87 Billion USD | 26.02% |
| 2021 Q3 | 9.42 Billion USD | -0.48% |
| 2021 Q2 | 9.46 Billion USD | 9.95% |
| 2020 Q2 | 7.7 Billion USD | -1.07% |
| 2020 Q3 | 8.27 Billion USD | 7.42% |
| 2020 FY | 34.42 Billion USD | 2.66% |
| 2020 Q1 | 7.78 Billion USD | -16.05% |
| 2020 Q4 | 10.48 Billion USD | 26.82% |
| 2019 FY | 33.53 Billion USD | 0.65% |
| 2019 Q4 | 9.27 Billion USD | 16.28% |
| 2019 Q1 | 8.07 Billion USD | -12.35% |
| 2019 Q2 | 8.21 Billion USD | 1.67% |
| 2019 Q3 | 7.97 Billion USD | -2.91% |
| 2018 Q2 | 8.38 Billion USD | 9.33% |
| 2018 FY | 33.31 Billion USD | 4.19% |
| 2018 Q4 | 9.21 Billion USD | 14.46% |
| 2018 Q3 | 8.05 Billion USD | -3.95% |
| 2018 Q1 | 7.66 Billion USD | -20.63% |
| 2017 Q3 | 8 Billion USD | 5.58% |
| 2017 Q4 | 9.66 Billion USD | 20.63% |
| 2017 FY | 31.97 Billion USD | 10.1% |
| 2017 Q1 | 6.83 Billion USD | -14.04% |
| 2017 Q2 | 7.58 Billion USD | 11.01% |
| 2016 FY | 29.04 Billion USD | -4.0% |
| 2016 Q2 | 7.44 Billion USD | 11.03% |
| 2016 Q1 | 6.7 Billion USD | -23.46% |
| 2016 Q3 | 6.95 Billion USD | -6.59% |
| 2016 Q4 | 7.94 Billion USD | 14.37% |
| 2015 Q1 | 6.74 Billion USD | -20.23% |
| 2015 Q3 | 7.23 Billion USD | -3.7% |
| 2015 FY | 30.24 Billion USD | -0.65% |
| 2015 Q4 | 8.75 Billion USD | 21.01% |
| 2015 Q2 | 7.51 Billion USD | 11.37% |
| 2014 Q2 | 7.48 Billion USD | 6.73% |
| 2014 Q4 | 8.45 Billion USD | 12.9% |
| 2014 Q3 | 7.49 Billion USD | 0.07% |
| 2014 Q1 | 7.01 Billion USD | -15.78% |
| 2014 FY | 30.44 Billion USD | 1.45% |
| 2013 Q3 | 7.35 Billion USD | 0.46% |
| 2013 Q1 | 7 Billion USD | -12.32% |
| 2013 FY | 30.01 Billion USD | 5.18% |
| 2013 Q4 | 8.32 Billion USD | 13.21% |
| 2013 Q2 | 7.32 Billion USD | 4.5% |
| 2012 FY | 28.53 Billion USD | 0.06% |
| 2012 Q4 | 7.99 Billion USD | 11.76% |
| 2012 Q3 | 7.15 Billion USD | 6.24% |
| 2012 Q1 | 6.66 Billion USD | -12.52% |
| 2012 Q2 | 6.73 Billion USD | 1.07% |
| 2011 FY | 28.51 Billion USD | 8.56% |
| 2011 Q4 | 7.61 Billion USD | 8.56% |
| 2011 Q3 | 7.01 Billion USD | -1.18% |
| 2011 Q2 | 7.09 Billion USD | 4.46% |
| 2011 Q1 | 6.79 Billion USD | -5.14% |
| 2010 Q3 | 6.36 Billion USD | -0.59% |
| 2010 FY | 26.26 Billion USD | -2.6% |
| 2010 Q1 | 6.33 Billion USD | -19.2% |
| 2010 Q2 | 6.4 Billion USD | 1.07% |
| 2010 Q4 | 7.16 Billion USD | 12.5% |
| 2009 Q3 | 6.38 Billion USD | -0.79% |
| 2009 Q4 | 7.84 Billion USD | 22.84% |
| 2009 Q2 | 6.43 Billion USD | 5.04% |
| 2009 Q1 | 6.12 Billion USD | -21.19% |
| 2009 FY | 26.96 Billion USD | -7.8% |
| 2008 Q1 | 6.83 Billion USD | -15.08% |
| 2008 FY | 29.24 Billion USD | 3.97% |
| 2008 Q4 | 7.77 Billion USD | 10.16% |
| 2008 Q3 | 7.05 Billion USD | -5.2% |
| 2008 Q2 | 7.44 Billion USD | 8.9% |
| 2007 Q2 | 6.89 Billion USD | 6.83% |
| 2007 Q1 | 6.45 Billion USD | -4.27% |
| 2007 FY | 28.13 Billion USD | 14.55% |
| 2007 Q4 | 8.04 Billion USD | 19.55% |
| 2007 Q3 | 6.73 Billion USD | -2.35% |
| 2006 Q4 | 6.74 Billion USD | 12.18% |
| 2006 FY | 24.55 Billion USD | 5.9% |
| 2006 Q1 | 5.62 Billion USD | -13.93% |
| 2006 Q2 | 6.17 Billion USD | 9.81% |
| 2006 Q3 | 6.01 Billion USD | -2.74% |
| 2005 Q2 | 5.8 Billion USD | 5.3% |
| 2005 Q4 | 6.53 Billion USD | 14.7% |
| 2005 Q3 | 5.7 Billion USD | -1.77% |
| 2005 Q1 | 5.51 Billion USD | -13.65% |
| 2005 FY | 23.18 Billion USD | 10.09% |
| 2004 Q3 | 5.05 Billion USD | 3.25% |
| 2004 Q2 | 4.89 Billion USD | 3.34% |
| 2004 Q4 | 6.38 Billion USD | 26.33% |
| 2004 FY | 21.06 Billion USD | 11.95% |
| 2004 Q1 | 4.73 Billion USD | -14.58% |
| 2003 Q3 | 4.6 Billion USD | 2.84% |
| 2003 Q1 | 4.18 Billion USD | -8.78% |
| 2003 Q4 | 5.54 Billion USD | 20.37% |
| 2003 FY | 18.81 Billion USD | 16.34% |
| 2003 Q2 | 4.47 Billion USD | 6.9% |
| 2002 Q4 | 4.59 Billion USD | 16.02% |
| 2002 FY | 16.17 Billion USD | 3.79% |
| 2002 Q3 | 3.95 Billion USD | 0.23% |
| 2002 Q2 | 3.94 Billion USD | 7.49% |
| 2002 Q1 | 3.67 Billion USD | -16.2% |
| 2001 FY | 15.58 Billion USD | 1.74% |
| 2001 Q4 | 4.38 Billion USD | 21.71% |
| 2001 Q3 | 3.6 Billion USD | -0.8% |
| 2001 Q2 | 3.63 Billion USD | 6.01% |
| 2001 Q1 | 3.42 Billion USD | -16.63% |
| 2000 Q1 | 3.67 Billion USD | -12.64% |
| 2000 Q2 | 3.54 Billion USD | -3.67% |
| 2000 Q3 | 3.5 Billion USD | -1.02% |
| 2000 Q4 | 4.1 Billion USD | 17.17% |
| 2000 FY | 15.31 Billion USD | 5.29% |
| 1999 Q4 | 4.2 Billion USD | 15.6% |
| 1999 FY | 14.54 Billion USD | 17.11% |
| 1999 Q1 | 3.41 Billion USD | -5.56% |
| 1999 Q2 | 3.5 Billion USD | 2.55% |
| 1999 Q3 | 3.64 Billion USD | 4.03% |
| 1998 FY | 12.42 Billion USD | 4.19% |
| 1998 Q1 | 2.88 Billion USD | -7.17% |
| 1998 Q4 | 3.61 Billion USD | 22.3% |
| 1998 Q3 | 2.95 Billion USD | -0.34% |
| 1998 Q2 | 2.96 Billion USD | 2.67% |
| 1997 Q2 | 2.93 Billion USD | 1.17% |
| 1997 Q4 | 3.11 Billion USD | 4.22% |
| 1997 Q3 | 2.98 Billion USD | 1.88% |
| 1997 Q1 | 2.89 Billion USD | -7.12% |
| 1997 FY | 11.92 Billion USD | 5.43% |
| 1996 FY | 11.3 Billion USD | 13.61% |
| 1996 Q1 | 2.66 Billion USD | -0.07% |
| 1996 Q4 | 3.11 Billion USD | 11.4% |
| 1996 Q3 | 2.79 Billion USD | 2.79% |
| 1996 Q2 | 2.72 Billion USD | 2.06% |
| 1995 FY | 9.95 Billion USD | 19.17% |
| 1995 Q4 | 2.67 Billion USD | 6.21% |
| 1995 Q3 | 2.51 Billion USD | 3.16% |
| 1995 Q1 | 2.27 Billion USD | 0.62% |
| 1995 Q2 | 2.43 Billion USD | 7.03% |
| 1994 Q2 | 2.04 Billion USD | 5.35% |
| 1994 Q3 | 2.09 Billion USD | 2.39% |
| 1994 FY | 8.35 Billion USD | 10.33% |
| 1994 Q4 | 2.26 Billion USD | 7.92% |
| 1994 Q1 | 1.94 Billion USD | -0.05% |
| 1993 FY | 7.57 Billion USD | 2.88% |
| 1993 Q4 | 1.94 Billion USD | 3.4% |
| 1993 Q3 | 1.88 Billion USD | 0.27% |
| 1993 Q1 | 1.87 Billion USD | -5.02% |
| 1993 Q2 | 1.87 Billion USD | 0.05% |
| 1992 Q4 | 1.97 Billion USD | 7.09% |
| 1992 FY | 7.35 Billion USD | 11.96% |
| 1992 Q3 | 1.84 Billion USD | 3.32% |
| 1992 Q1 | 1.75 Billion USD | 0.06% |
| 1992 Q2 | 1.78 Billion USD | 1.83% |
| 1991 Q2 | 1.57 Billion USD | -2.85% |
| 1991 FY | 6.57 Billion USD | 13.76% |
| 1991 Q1 | 1.61 Billion USD | 17.7% |
| 1991 Q4 | 1.75 Billion USD | 7.09% |
| 1991 Q3 | 1.63 Billion USD | 4.14% |
| 1990 FY | 5.77 Billion USD | 14.85% |
| 1990 Q3 | 1.52 Billion USD | 11.52% |
| 1990 Q1 | 1.46 Billion USD | 11.71% |
| 1990 Q4 | 1.37 Billion USD | -10.2% |
| 1990 Q2 | 1.37 Billion USD | -6.67% |
| 1989 Q4 | 1.31 Billion USD | 4.78% |
| 1989 FY | 5.03 Billion USD | 7.14% |
| 1989 Q2 | - USD | -100.0% |
| 1989 Q1 | 1.24 Billion USD | 0.0% |
| 1989 Q3 | 1.25 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbbVie Inc. | 24.83 Billion USD | -135.981% |
| Bristol-Myers Squibb Company | 34.31 Billion USD | -70.798% |
| Bristol-Myers Squibb Company Ce | 34.31 Billion USD | -70.798% |
| Eli Lilly and Company | 16.71 Billion USD | -250.588% |
| Merck & Co., Inc. | 43.98 Billion USD | -33.229% |
| Novartis AG | 24.87 Billion USD | -135.64% |
| Organon & Co. | 2.41 Billion USD | -2322.737% |
| Pfizer Inc. | 25.45 Billion USD | -130.279% |